THE GEMMA ROSE FOUNDATION
RECEIPTS AND PAYMENTS ACCOUNT FOR THE YEAR ENDED 06/04/2022
CHARITY NUMBER 1184730
THE GEEMA ROSE FOUNDATION
CONTENTS PAGE
-
RECEIPTS AND PAYMENTS ACCOUNT
-
STATEMENT OF ASSETS AND LIABILITIES
THE GEMMA ROSE FOUNDATION
THE GEMMA ROSE FOUNDATION
REGISTERED CHARITY NO 1184730
RECEIPTS AND PAYMENTS ACCOUNT FOR THE YEAR ENDED 06/04/2022
| 2022 | 2021 | |
|---|---|---|
| Receipts | ||
| Donations, legacies, and other similar receipts | ||
| Donations | 0 |
0 |
| Sponsorship | ||
| Operating Activities to further the charity’s objectives | ||
| Total Receipts | 0 | 0 |
| ---------- ---------- ---------- ---------- ----- | ||
| Payments | ||
| Payments for generating funds | ||
| Charitable Payments | ||
| Support Costs | 96 | 55 |
| Total Payments | ---------- ---------- ---------- ---------- ----- | |
| Net Receipts/Payments | 227,373 | 227,469 |
| ---------- ---------- ---------- ---------- ----- |
THE GEMMA ROSE FOUNDATION
REGISTERED CHARITY NO 1184730 STATEMENT OF ASSETS AND LIABILITES AS AT 05/04/2020
Cash Funds Current Account 227, 373 Total Cash Funds 227, 373
The charity has no Other Monetary Assets, Investment Assets or Assets Retained for the Charity’s Own Use as at the year end.
The Charity has no Liabilities as at the year end.
Signed by the Trustee, Julie Gibson, on behalf of the Trustees:
Date: 12[th] February 2023
The Trustee’s Annual Meeting Minutes. 10[th] February 2023
Agenda
1. Accounts
2. Status
3. Closure
4. Options
1. Accounts
No issues or concerns reported.
2. Status
It was reported to JG (via P.A. to KW) that KW does not feel the bandwidth is available to launch the charity.
JG requested clarity around next steps.
3. Closure
JG - If the charity is to close due to lack of KW bandwidth it must be done so in accordance with charity commission procedures and protocols.
JG to discuss further with P.A. to KW
4. Options
JG was asked for comment and opinion regarding the use of current funds if charity does not proceed. JG advised that it was not appropriate for JG to stipulate the use of the majority of funds as these were raised prior to JG coming on board. However JG felt that there was an opportunity to still carry out some good and fulfil the purpose for assisting and joining the venture.
JG advised P.A. to KW that a paper will be submitted for the use of £17,400 in the trial of a new treatment. It was agreed this would be discussed further at a meeting.